![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2004, The National Academy of Sciences Microbiology Multiple substrates of the Legionella pneumophila Dot/Icm system identified by interbacterial protein transfer Howard Hughes Medical Institute and Department of Molecular Biology and Microbiology, Tufts University School of Medicine, 150 Harrison Avenue, Boston, MA 02111 * To whom correspondence should be addressed. E-mail: ralph.isberg/at/tufts.edu. Edited by John J. Mekalanos, Harvard Medical School, Boston, MA, and approved November 21, 2003 Received August 2, 2003. This article has been cited by other articles in PMC.Abstract Legionella pneumophila is an intracellular pathogen that multiplies in a specialized vacuole within host cells. Biogenesis of this vacuole requires the Dot/Icm type IV protein translocation system. By using a Cre/loxP-based protein translocation assay, we found that proteins translocated by the Dot/Icm complex across the host phagosomal membrane can also be transferred from one bacterial cell to another. The flexibility of this system allowed the identification of several families of proteins translocated by the Dot/Icm complex. When analyzed by immunofluorescence microscopy, a protein identified by this procedure, SidC, was shown to translocate across the phagosomal membranes to the cytoplasmic face of the L. pneumophila phagosome. The identification of large numbers of these substrates, and the fact that the absence of any one substrate rarely results in strong defects in intracellular growth, indicate that there is significant functional redundancy among the Dot/Icm translocation targets. Keywords: bacterial pathogenesis, protein translocation, plasmid conjugation Active modification of host cellular functions is essential for a bacterial pathogen to establish a successful infection. Such modification often is mediated by injecting effectors into the host cytoplasm through specialized protein secretion systems (1). Among these systems, conjugation-adaptive transporters, also called type IV secretion systems (TFSS), have been identified in a number of bacterial pathogens (2). Many of these TFSS are dedicated DNA transfer apparatuses, whereas others allow Gram-negative bacterial pathogens to translocate protein substrates directly into the cytosol of eukaryotic cells. Only a few protein substrates of TFSS that are translocated into host cells have been identified (2). Legionella pneumophila is an intracellular pathogen that causes Legionnaire's disease. After being phagocytosed by macrophages, the bacteria multiply within a specialized vacuole that is initially isolated from the endocytic pathway (3, 4), possibly by intercepting early secretory vesicles (5). Biogenesis of this replicative phagosome requires the TFSS transporter called Dot/Icm (6, 7). Substrates transported by this apparatus are believed to directly promote the targeting pathway of the bacterial vacuole (8). Two of these substrates, RalF and LidA, have been identified (9, 10). RalF is a guanine nucleotide exchange factor for multiple Arf proteins (9), whereas the biochemical activity of LidA is unknown (10). There are clearly other unidentified substrates of Dot/Icm, as mutations that specifically eliminate LidA cause negligible defects in intracellular growth and mutations in ralF are proficient for intracellular replication (9, 10). A comprehensive analysis of the identity and function of effectors translocated by the Dot/Icm apparatus is crucial in determining how this bacterium establishes a replication vacuole. We report here that proteins translocated from bacteria to host cells can also be transferred between bacterial cells, allowing identification of a large cohort of proteins transferred by the Dot/Icm apparatus. Materials and Methods Bacterial Strains and Growth Conditions. All L. pneumophila strains used in this study are derivatives of the wild-type strain Lp02 (thyA, hsdR, and rpsL) (11). Lp03 is an isogenic dotA– mutant (12). All strains were grown on casamino acids yeast extract thymidine (CYET) plates or in N-(2-acetamido)-2-aminoethanesulfonic acid yeast extract (AYE) broth (11). Bone marrow-derived macrophages were prepared as described (11). To assay for intracellular growth within macrophages from A/J mice (11) or within the amoebal host Dictyostelium discoideum (13), L. pneumophila strains were grown to postexponential phase, as judged by bacterial motility and cell density (OD600 = 3.3–3.7). Plasmid Constructions. A derivative of pBRR1MCS mob– (Cmr) (14), which was suitable for reporting interbacterial protein translocation (called pZL184; Fig. 1
Bacterial Two-Hybrid Screening. First, ralF was translationally fused to the 3′ end of fragment T18 of the Bordetella pertussis cya gene, encoding adenylate cyclase, on pUT18 (15). Sau3AI-generated genomic DNA fragments from L. pneumophila strain Lp02 (11), ranging from 800 base pairs to 5 kb, were inserted into pKT25 (15), resulting in a library of L. pneumophila proteins fused to the C terminus of B. pertussis adenylate cyclase T25 fragment. Escherichia coli strain BTH101 (15), expressing cya::ralF(C), was used to identify RalF-interacting proteins by screening either on LB medium containing 40 μg/ml X-Gal or on the synthetic M63 medium (15) with lactose as the sole carbon source. Strains with functional adenylate cyclase proteins were identified based on the presence of detectable Lac+ phenotypes on these media. Proteins that interact with DotF were identified in a similar manner by using either DotF or DotF (28–123) as the bait. Bacterial Matings and Intercellular Protein Translocation. For RP4 Trb-mediated translocation of the Cre::MobA hybrid, ≈2.5 × 108 cells from saturated cultures of S17–1 (Trb+) (16) or DH5α (Trb–) expressing the fusion grown in LB broth were mixed with a 15-fold excess of recipient strain XL1Blue carrying pZL184. The mixtures were spotted onto 0.45-μm nitrocellulose filters, placed on LB plates, and incubated at 37°C for 3 h. The excisants were selected on LB medium containing 5% sucrose and 30 μg/ml kanamycin. For L. pneumophila to L. pneumophila translocation, Lp02 (11) or Lp03dotA– (12) containing plasmids expressing the appropriate Cre fusions were grown to postexponential phase in AYE broth. For matings, 0.45-μm nitrocellulose membranes were first placed onto CYET medium containing 100 nM isopropyl β-d-thiogalactoside (IPTG) and the plates were incubated at 37°C for 1 h before spotting with a mixture of ≈3.5 × 108 donor and a 15-fold excess of recipient Lp03(pZL184). The mating plates were incubated at 37°C for 14 h and excisants were selected on CYET –5% sucrose, 30 μg/ml kanamycin, which kills both parents. Each mating was performed in triplicate and repeated at least three times. Transfer frequencies were expressed as number of excisants (resistant to kanamycin and sucrose but sensitive to gentamicin) per donor bacterium and the number of donor bacteria was determined by counting colonyforming units derived from appropriately diluted donor cells plated onto CYET medium before mating. For plasmid transfer, transconjugants were detected by plating the protein translocation mating mixture onto LB containing 100 μg/ml ampicillin and 30 μg/ml chroramphenicol (for E. coli) or onto charcoal yeast extract containing 5 μg/ml chloramphenicol (selecting Thy+ and CmR) for transfer in L. pneumophila). As a positive control, the wild-type RSF1010 derivative pKB5 (11) was used in both E. coli and L. pneumophila matings (6). Construction of In-Frame Deletions and Complementation of the Deletion Mutants. In-frame deletions of L. pneumophila genes were performed by a two-step allelic exchange strategy as described (17). In each case, the deletion construct was designed such that the intact gene was replaced by an ORF predicted to express a 20-aa polypeptide consisting of the first 10 amino acids and the last 10 amino acids of the gene. To perform complementation studies on deletion mutants, the gene of interest was amplified by PCR and inserted into pJB908 or pBBRMCS2 (14). Protein Purification and Antibody Preparation. The predicted ORF of SidC was inserted into pQE30 and the resulting His6-SidC fusion protein was purified from E. coli by using Ninitrilotriacetic acid resin (Qiagen, Valencia, CA). Rabbit polyclonal serum was generated by the Pocono Rabbit Farm (Canadensis, PA; ref. 10). Antibodies were affinity-purified by using a matrix containing purified (His)6-SidC covalently coupled to Affigel-10 beads (Bio-Rad) (18). Western Blot and Immunofluorescence Staining. Total L. pneumophila proteins separated by SDS/PAGE were transferred onto Immobilon-P membranes (Millipore) and probed by Western blotting, as described (16). Filters were probed with affinity-purified anti-SidC antibody (diluted 1:5,000), or anti-Bacillus subtilis isocitrate dehydrogenase polyclonal antibody (diluted 1:5,000; a kind gift from Dr L. Sonenshein, Tufts University School of Medicine). Immunofluorescence staining was performed with affinity-purified rabbit anti-(His)6-SidC antibodies followed by a Texas red-conjugated goat anti-rabbit antibody (Molecular Probes). Fixation and probing techniques were performed as described (10). Postnuclear L. pneumophila phagosomes were isolated as described (10). Results Interbacterial Protein Translocation by Dot/Icm. To identify substrates of the Dot/Icm translocator, a screening strategy was devised that allowed us to directly assay for protein translocation, using the Cre/loxP system from bacteriophage P1 (for review, see ref.19). Previous work (20) demonstrated that the presence of Cre does not interfere with the translocation of the TFSS substrates VirE2 and VirF in Agrobacterium tumefaciens. A reporter suitable for monitoring translocation of Cre fusion proteins between two prokaryotic cells was constructed in which expression of the npt II gene depended on the excision of a floxed cassette consisting of a gentamicin resistance gene, the sacB gene, and a transcriptional terminator (Fig. 1 A Two proteins known to be transferred from bacterial cells to mammalian cells could also be translocated interbacterially by using this strategy. Full-length ralF and the 3′ half of lidA [called lidA(C)] were each translationally fused to cre and the resulting hybrids were examined for bacterium-bacterium translocation. We found that wild type L. pneumophila, but not a Dot/Icmdeficient strain, could transfer Cre::RalF or Cre::LidA(C), based on the ability of recipient strain to excise the floxed DNA fragment and to express kanamycin resistance [Fig. 1D Identification of Substrates of the Dot/Icm Transporter. Because the translocated proteins LidA and RalF could be transferred interbacterially, we used the bacterial translocation assay to identify proteins transferred by this transporter. To simplify the screening of a randomly generated fusion library, we chose to screen through a preselected pool of candidate substrates. We hypothesized that some translocated substrates may interact with specific components of the Dot/Icm complex. Therefore, a bacterial two-hybrid screen (15) was used to identify L. pneumophila proteins that specifically interacted with the carboxyl portion of RalF. From 41 positive clones sequenced, DotF, predicted to be an inner membrane component of the Dot/Icm complex, was identified nine times independently. Interestingly, in all cases, only the portion of DotF that spans amino acids 28–123 was obtained. The full-length DotF also gave a positive two-hybrid readout, although at a somewhat lower level (Fig. 2
Characteristics of sid Genes. Sequence analyses revealed that with the exception of sidB, the sid genes have no significant orthologs present in the GenBank NR database (Table 1). SidB contains a putative active site found in some lipases and shows a region similar to a portion of the Rtx toxin from Vibrio cholerae (24). In contrast, many of these proteins have one or more paralogs present in the L. pneumophila genome (Table 1). The similarities among the paralogs range from almost identical predicted proteins (E = 0) to rather loose similarity (E = 5e–2 to 2e–8; Table 1). Interestingly, in some cases, subsets of paralogs are organized into contiguous ORFs. For instance, sidC and its homolog sdcA are separated by only 150 base pairs, whereas sdeA, sdeB, and sdeC are closely clustered (Fig. 3
SidC Is Translocated by Dot/Icm Into the Cytosol of Host Cells. To verify that proteins identified in our assay are translocated into mammalian cells, affinity-purified antiserum against His6-SidC was used to analyze expression and translocation of SidC by L. pneumophila. As predicted, a protein of ≈110 kDa was detected in both a dot/icm+ strain and a dotA– mutant of L. pneumophila, but not in a mutant missing sidC and its paralog sdcA [Δ(sdcA-sidC)] (Fig. 3C
Because the above strategy only detects secretion of SidC and does not demonstrate translocation across the phagosomal membrane, a second approach was pursued (10). To demonstrate SidC translocation across the phagosomal membrane by the Dot/Icm transporter, we prepared postnuclear supernatants (PNS) from macrophages incubated with L. pneumophila and probed intact phagosomes for SidC in the absence of permeabilization reagents. Approximately 85% of these phagosomes stained positively for SidC (Fig. 4 B and E SdeC Is Required for Efficient Intracellular Growth by L. pneumophila. To examine the importance of the Sid proteins in L. pneumophila pathogenesis, we constructed in-frame deletions in some of these genes and tested the resulting mutants for intracellular growth in bone marrow-derived macrophages (10). Individual deletions of sidA, sidD, sidF, or sidG, which have no detectable paralogs in the available L. pneumophila database, resulted in strains with intracellular growth properties that were difficult to distinguish from the wild-type strain. Furthermore, a mutant lacking sidC and its upstream paralog sdcA grew proficiently (data not shown). Finally, a quadruple mutant lacking sidB and its three paralogs has a defect in intracellular growth, but this result was not significantly different from a mutant missing sdbA alone (data not shown), suggesting that functional redundancy extends beyond specific substrate families. We then constructed in-frame deletion mutants lacking individual paralogs of sidE and examined intracellular growth of these mutants in bone marrow-derived or in D. discoideum. Unexpectedly, only deletion of the single paralog sdeC had a detectable growth defect (Fig. 5
Discussion By developing a genetic assay for monitoring protein translocation using the cre/loxP system, we conclusively demonstrated that the Dot/Icm TFSS transporter can perform interbacterial transfer of proteins known to be targeted to mammalian cells, an observation that we have exploited to identify a large number of translocated proteins. The majority of the proteins we identified have no significant orthologs in the database, suggesting that biogenesis of the L. pneumophila replication compartment may involve mechanisms that differ from other organisms, such as Chlamydia trachomatis and Mycobacterium spp., which reside in similar intracellular vacuoles. Alternatively, proteins with similar functions in different microbial species may have evolved independent of each other, and show little sequence similarity to each other. Many of the translocated proteins have paralogs within L. pneumophila, often encoded in chromosomal regions devoted to expression of translocated substrates of Dot/Icm (Fig. 3 A and B The lack of intracellular growth defects observed in L. pneumophila mutants lacking translocated substrates is reminiscent of a L. pneumophila ralF mutant, which is indistinguishable from the parental wild-type strain in regards to intracellular growth (9). Nevertheless, a ralF mutant is unable to recruit Arf1 to the surface of the replicative phagosome, a property that may play some unknown role in the lifestyle of the organism (27). It is possible that elimination of some of the genes here identified similarly results in the formation of phagosomes with alterations in either morphology or host protein content that have little consequence with respect to growth in cultured cells. Alternatively, the roles played by these proteins may be substituted by other substrates of Dot/Icm, or some of these proteins may be important for growth in some untested host cell. It is common that a bacterial pathogen codes for numerous effectors but the presence of multiple paralogs of a specific translocated effector in the same organism is only occasionally found (28–30). The close similarity among proteins in a family points to functional redundancy, which may provide an explanation for the failure to identify these proteins in previous genetic screens for bacterial mutants defective in intracellular growth. In the case of the sidB family, however, functional redundancy clearly extends beyond the identified paralogs, and proteins of little similarity in sequence or function may be redundant. It is plausible that each paralog may be adapted to promote growth only in specific host cells. Because L. pneumophila is a versatile pathogen that interacts with very diverse hosts in the environment, the establishment of a successful intracellular replication niche may require only a subset of translocated substrates, with a single subset adapted for a particular host cell type. Sorting out the minimal complement of translocated proteins necessary for intracellular replication will be a challenge for the future, because the number of such proteins may be quite large, based on the data displayed in Table 1. In addition to the products of the genes identified in the original Cre/loxP assay and sdeC, we have tested four paralogs of Sid proteins for interbacterial transfer, and all can promote transfer of Cre (data not shown). Based on this finding, we speculate that it is likely that all of the paralogs are capable of translocation. Furthermore, in another study we found an additional family of four proteins that can be transferred (S. M. VanRheenen, Z.-Q.L., and R.R.I., unpublished results). Altogether, this brings the minimum number of translocated proteins encoded by L. pneumophila to 24. In fact, there are probably many more proteins translocated by Dot/Icm, as the DotF interaction screen was not carried to saturation. The gene bank required in-frame fusions to a Sau3AI restrictions site, which may not be present in all genes encoding translocated substrates. Furthermore, the screen described here focused on only the subset of DotF interactors, and it appears that not all translocated substrates bind DotF at detectable levels in this assay. The other salient feature of the Dot/Icm translocation system that was uncovered here is the large size of the proteins that were translocated. Many of the proteins identified in this study are >90 kDa, with one predicted to be >240 kDa. It appears likely that TFSS have evolved to transport large molecules, such as DNA–protein complexes, and these transfer systems may be the preferred translocators for high molecule weight substrates. In summary, the L. pneumophila TFSS is a transporter system of striking flexibility. It is capable of promoting bacterial conjugation and translocation of proteins from bacteria into mammalian cells, as well as transporting these same proteins between bacterial strains. Although the efficiency of interbacterial protein transfer appears to be many orders of magnitude lower than the transfer from bacteria to macrophages (Table 1 and Figs. Figs.1D1D Supporting Information
Acknowledgments We thank M. Tang for assistance in protein purification; S. Farrand, D. Ladant, A. Vergunst, and J. Vogel for supplying plasmids; the Isberg laboratory for helpful discussions; and Drs. Carol Kumamoto, Michael Malamy, Susan VanRheeven, Marion Shonn, Isabelle Derre, and Matthias Machner for review of the text. This work was supported by the Howard Hughes Medical Institute. Z.-Q.L. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation, and R.R.I. is a Howard Hughes Medical Institute Investigator. Notes This paper was submitted directly (Track II) to the PNAS office. Abbreviations: TFSS, type IV secretion systems; Sid, substrate of Icm/Dot transporter. Data deposition: The sequence reported in this paper has been deposited in the GenBank database (accession nos. AY504668–AY504685). References 1. Staskawicz, B. J., Mudgett, M. B., Dangl, J. L. & Galan, J. E. (2001. ) Science 292, 2285–2289. [PubMed] 2. Christie, P. J. (2001. ) Mol. Microbiol. 40, 294–305. [PubMed] 3. Horwitz, M. A. (1983. ) J. Exp. Med. 158, 2108–2126. [PubMed] 4. Sturgill-Koszycki, S. & Swanson, M. S. (2000. ) J. Exp. Med. 192, 1261–1272. [PubMed] 5. Kagan, J. C. & Roy, C. R. (2002. ) Nat. Cell Biol. 4, 945–954. [PubMed] 6. Vogel, J. P., Andrews, H. L., Wong, S. K. & Isberg, R. R. (1998. ) Science 279, 873–876. [PubMed] 7. Segal, G., Purcell, M. & Shuman, H. A. (1998. ) Proc. Natl. Acad. Sci. USA 95, 1669–1674. [PubMed] 8. Vogel, J. P. & Isberg, R. R. (1999. ) Curr. Opin. Microbiol. 2, 30–34. [PubMed] 9. Nagai, H., Kagan, J. C., Zhu, X., Kahn, R. A. & Roy, C. R. (2002. ) Science 295, 679–682. [PubMed] 10. Conover, G. M., Derre, I. I., Vogel, J. P. & Isberg, R. R. (2003. ) Mol. Microbiol. 48, 305–321. [PubMed] 11. Berger, K. H. & Isberg, R. R. (1993. ) Mol. Microbiol. 7, 7–19. [PubMed] 12. Berger, K. H., Merriam, J. J. & Isberg, R. R. (1994. ) Mol. Microbiol. 14, 809–822. [PubMed] 13. Solomon, J. M., Rupper, A., Cardelli, J. A. & Isberg, R. R. (2000. ) Infect. Immun. 68, 2939–2947. [PubMed] 14. Kovach, M. E., Elzer, P. H., Hill, D. S., Robertson, G. T., Farris, M. A., Roop, R. M. & Peterson, K. M. (1995. ) Gene 166, 175–176. [PubMed] 15. Karimova, G., Pidoux, J., Ullmann, A. & Ladant, D. (1998. ) Proc. Natl. Acad. Sci. USA 95, 5752–5756. [PubMed] 16. Simon, R., Priefer, U. & Puhler, A. (1983. ) Bio/Technology 1, 37–45. 17. Dumenil, G. & Isberg, R. R. (2001. ) Mol. Microbiol. 40, 1113–1127. [PubMed] 18. Harlow, E. & Lane, D. (1999. ) in Using Antibodies, A Laboratory Manual (Cold Spring Harbor Lab. Press, Plainview, NY), pp. 311–343. 19. Van Duyne, G. D. (2001. ) Annu. Rev. Biophys. Biomol. Struct. 30, 87–104. [PubMed] 20. Vergunst, A. C., Schrammeijer, B., den Dulk-Ras, A., de Vlaam, C. M., Regensburg-Tuink, T. J. & Hooykaas, P. J. (2000. ) Science 290, 979–982. [PubMed] 21. Christie, P. J. (1997. ) J. Bacteriol. 179, 3085–3094. [PubMed] 22. Wilkins, B. M. & Thomas, A. T. (2000. ) Mol. Microbiol. 38, 650–657. [PubMed] 23. Simone, M., McCullen, C. A., Stahl, L. E. & Binns, A. N. (2001. ) Mol. Microbiol. 41, 1283–1293. [PubMed] 24. Lin, W., Fullner, K. J., Clayton, R., Sexton, J. A., Rogers, M. B., Calia, K. E., Calderwood, S. B., Fraser, C. & Mekalanos, J. J. (1999. ) Proc. Natl. Acad. Sci. USA 96, 1071–1076. [PubMed] 25. Byrne, B. & Swanson, M. S. (1998. ) Infect. Immun. 66, 3029–3034. [PubMed] 26. Hammer, B. K. & Swanson, M. S. (1999. ) Mol. Microbiol. 33, 721–731. [PubMed] 27. Roy, C. R. & Tilney, L. G. (2002. ) J. Cell Biol. 158, 415–419. [PubMed] 28. Hartman, A. B., Venkatesan, M., Oaks, E. V. & Buysse, J. M. (1990. ) J. Bacteriol. 172, 1905–1915. [PubMed] 29. Stender, S., Friebel, A., Linder, S., Rohde, M., Mirold, S. & Hardt, W. D. (2000. ) Mol. Microbiol. 36, 1206–1221. [PubMed] 30. Miao, E. A., Scherer, C. A., Tsolis, R. M., Kingsley, R. A., Adams, L. G., Baumler, A. J. & Miller, S. I. (1999. ) Mol. Microbiol. 34, 850–864. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Science. 2001 Jun 22; 292(5525):2285-9.
[Science. 2001]Mol Microbiol. 2001 Apr; 40(2):294-305.
[Mol Microbiol. 2001]J Exp Med. 1983 Dec 1; 158(6):2108-26.
[J Exp Med. 1983]J Exp Med. 2000 Nov 6; 192(9):1261-72.
[J Exp Med. 2000]Nat Cell Biol. 2002 Dec; 4(12):945-54.
[Nat Cell Biol. 2002]Science. 1998 Feb 6; 279(5352):873-6.
[Science. 1998]Proc Natl Acad Sci U S A. 1998 Feb 17; 95(4):1669-74.
[Proc Natl Acad Sci U S A. 1998]Mol Microbiol. 1993 Jan; 7(1):7-19.
[Mol Microbiol. 1993]Mol Microbiol. 1994 Nov; 14(4):809-22.
[Mol Microbiol. 1994]Infect Immun. 2000 May; 68(5):2939-47.
[Infect Immun. 2000]Gene. 1995 Dec 1; 166(1):175-6.
[Gene. 1995]Proc Natl Acad Sci U S A. 1998 May 12; 95(10):5752-6.
[Proc Natl Acad Sci U S A. 1998]Mol Microbiol. 1993 Jan; 7(1):7-19.
[Mol Microbiol. 1993]Mol Microbiol. 1993 Jan; 7(1):7-19.
[Mol Microbiol. 1993]Mol Microbiol. 1994 Nov; 14(4):809-22.
[Mol Microbiol. 1994]Mol Microbiol. 1993 Jan; 7(1):7-19.
[Mol Microbiol. 1993]Science. 1998 Feb 6; 279(5352):873-6.
[Science. 1998]Mol Microbiol. 2001 Jun; 40(5):1113-27.
[Mol Microbiol. 2001]Gene. 1995 Dec 1; 166(1):175-6.
[Gene. 1995]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]Annu Rev Biophys Biomol Struct. 2001; 30():87-104.
[Annu Rev Biophys Biomol Struct. 2001]Science. 2000 Nov 3; 290(5493):979-82.
[Science. 2000]J Bacteriol. 1997 May; 179(10):3085-94.
[J Bacteriol. 1997]Mol Microbiol. 2000 Nov; 38(3):650-7.
[Mol Microbiol. 2000]Science. 2000 Nov 3; 290(5493):979-82.
[Science. 2000]Mol Microbiol. 2001 Sep; 41(6):1283-93.
[Mol Microbiol. 2001]Proc Natl Acad Sci U S A. 1998 May 12; 95(10):5752-6.
[Proc Natl Acad Sci U S A. 1998]Proc Natl Acad Sci U S A. 1999 Feb 2; 96(3):1071-6.
[Proc Natl Acad Sci U S A. 1999]Science. 2002 Jan 25; 295(5555):679-82.
[Science. 2002]Infect Immun. 1998 Jul; 66(7):3029-34.
[Infect Immun. 1998]Mol Microbiol. 1999 Aug; 33(4):721-31.
[Mol Microbiol. 1999]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]Science. 2002 Jan 25; 295(5555):679-82.
[Science. 2002]J Cell Biol. 2002 Aug 5; 158(3):415-9.
[J Cell Biol. 2002]J Bacteriol. 1990 Apr; 172(4):1905-15.
[J Bacteriol. 1990]Mol Microbiol. 1999 Nov; 34(4):850-64.
[Mol Microbiol. 1999]Proc Natl Acad Sci U S A. 1998 May 12; 95(10):5752-6.
[Proc Natl Acad Sci U S A. 1998]Mol Microbiol. 1993 Jan; 7(1):7-19.
[Mol Microbiol. 1993]Gene. 1995 Dec 1; 166(1):175-6.
[Gene. 1995]Mol Microbiol. 1993 Jan; 7(1):7-19.
[Mol Microbiol. 1993]Mol Microbiol. 1994 Nov; 14(4):809-22.
[Mol Microbiol. 1994]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]Infect Immun. 2000 May; 68(5):2939-47.
[Infect Immun. 2000]